Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nishant Jindal

Showing results (21-30 of 33) with videos related to

Pageof 4
Sort By:
Blood Cell Therapy|June 8, 2026
Outcomes of PTCY-Based Haploidentical Transplants and Donor Factors Affecting Outcomes: A 12-year Experience from IndiaNishant Jindal, Anant Gokarn, Malini Garg, et al.
The Indian Journal of Medical Research|April 5, 2021
Use of convalescent plasma for COVID-19 in India: A review & practical guidelinesNiranjan Shiwaji Khaire, Nishant Jindal, Lakshmi Narayana Yaddanapudi, et al.
British Journal of Haematology|December 18, 2022
Long-term real-world outcomes of patients with acute promyelocytic leukaemia treated with arsenic trioxide and all-trans retinoic acid without chemotherapy-a retrospective, single-centre studyCharanpreet Singh, Uday Yanamandra, Parathan Karunakaran, et al.
Leukemia Research|September 29, 2023
Factors associated with thrombo-hemorrhagic deaths in patients with Acute Promyelocytic leukemia treated with Arsenic Trioxide and all-trans retinoic acidCharanpreet Singh, Parathan Karunakaran, Uday Yanamandra, et al.
Cancer Medicine|July 16, 2025
Moving Beyond G-CSF Mobilization-Learning From a 15-Year Experience of Different Stem Cell Mobilization Regimens in Multiple MyelomaSumeet Mirgh, Bhausaheb Bagal, Sachin Punatar, et al.
Ejhaem|December 12, 2025
Multiple Myeloma in Young Adults-Insights From a Tertiary Care Cancer Centre in IndiaGeorge John, Sumeet Mirgh, Sachin Punatar, et al.
Cytotherapy|February 4, 2025
A comparison of mobilization regimens used in Hodgkin lymphoma and factors that influence peripheral blood stem cell mobilizationAnant Gokarn, Laxma Reddy, Sumathi Hiregoudar, et al.
Annals of Hematology|December 8, 2019
Randomized controlled trial of twice-daily versus alternate-day oral iron therapy in the treatment of iron-deficiency anemiaRahul Kaundal, Prateek Bhatia, Arihant Jain, et al.
International Immunopharmacology|June 13, 2023
Withaferin-A alleviates acute graft versus host disease without compromising graft versus leukemia effectSaurabh Kumar Gupta, Dievya Gohil, Deepshikha Dutta, et al.
Hemasphere|April 3, 2024
Circulating tumor plasma cells and peripheral blood measurable residual disease assessment in multiple myeloma patients not planned for upfront transplantPrashant R Tembhare, Harshini Sriram, Twinkle Khanka, et al.
Pageof 4

Showing results (21-30 of 33) with videos related to

Sort By:
Pageof 4
Blood Cell Therapy|June 8, 2026
Outcomes of PTCY-Based Haploidentical Transplants and Donor Factors Affecting Outcomes: A 12-year Experience from IndiaNishant Jindal, Anant Gokarn, Malini Garg, et al.
The Indian Journal of Medical Research|April 5, 2021
Use of convalescent plasma for COVID-19 in India: A review & practical guidelinesNiranjan Shiwaji Khaire, Nishant Jindal, Lakshmi Narayana Yaddanapudi, et al.
British Journal of Haematology|December 18, 2022
Long-term real-world outcomes of patients with acute promyelocytic leukaemia treated with arsenic trioxide and all-trans retinoic acid without chemotherapy-a retrospective, single-centre studyCharanpreet Singh, Uday Yanamandra, Parathan Karunakaran, et al.
Leukemia Research|September 29, 2023
Factors associated with thrombo-hemorrhagic deaths in patients with Acute Promyelocytic leukemia treated with Arsenic Trioxide and all-trans retinoic acidCharanpreet Singh, Parathan Karunakaran, Uday Yanamandra, et al.
Cancer Medicine|July 16, 2025
Moving Beyond G-CSF Mobilization-Learning From a 15-Year Experience of Different Stem Cell Mobilization Regimens in Multiple MyelomaSumeet Mirgh, Bhausaheb Bagal, Sachin Punatar, et al.
Ejhaem|December 12, 2025
Multiple Myeloma in Young Adults-Insights From a Tertiary Care Cancer Centre in IndiaGeorge John, Sumeet Mirgh, Sachin Punatar, et al.
Cytotherapy|February 4, 2025
A comparison of mobilization regimens used in Hodgkin lymphoma and factors that influence peripheral blood stem cell mobilizationAnant Gokarn, Laxma Reddy, Sumathi Hiregoudar, et al.
Annals of Hematology|December 8, 2019
Randomized controlled trial of twice-daily versus alternate-day oral iron therapy in the treatment of iron-deficiency anemiaRahul Kaundal, Prateek Bhatia, Arihant Jain, et al.
International Immunopharmacology|June 13, 2023
Withaferin-A alleviates acute graft versus host disease without compromising graft versus leukemia effectSaurabh Kumar Gupta, Dievya Gohil, Deepshikha Dutta, et al.
Hemasphere|April 3, 2024
Circulating tumor plasma cells and peripheral blood measurable residual disease assessment in multiple myeloma patients not planned for upfront transplantPrashant R Tembhare, Harshini Sriram, Twinkle Khanka, et al.
Pageof 4